Weekly round-up #253

Welcome

Welcome New Members

We are very happy to welcome 14 new members to VALIDATE from 11 countries.

Investigators

Associates

Affiliates

 

benefits infographic

We welcome new members (especially from LMICs)

Recently, the VALIDATE Community grew to over 600 VALIDATE members. This is great news, but we think we can do better. Though Lower and Middle-Income Countries (LMICs) are well represented, we are perhaps not reaching as many researchers in the ‘least-developed’ countries list as we would like.

We are still missing connections in the below countries, so if you know any researchers there working on research contributing to the advancement of vaccines for our focus pathogens, please do invite them to join VALIDATE.

 

 

We are keen to be represented in the following LMICs:

  • Afghanistan
  • Angola
  • Benin
  • Bhutan
  • Burundi
  • Cambodia
  • Central African Republic
  • Chad
  • Comoros
  • DRC
  • Djibouti
  • Eritrea
  • Guinea
  • Guinea-Bissau
  • Lao
  • Lesotho
  • Liberia
  • Madagascar
  • Mali
  • Mauritania
  • Myanmar
  • Niger
  • Rwanda
  • Sao Tome & Principe
  • Sierra Leone
  • Solomon Islands
  • South Sudan
  • Timor-Leste
  • Togo
  • Tuvalu
  • Yemen

 

If you know researchers in those countries, remind them about the benefits of VALDIATE membership and encourage them to join - www.validate-network.org/joining-validate

Funding:

You can find a list of all relevant external funding we've spotted for our members on our external funding page.​​

Training Opportunities and Events:

Find more event opportunities on our Training and Events pages.

Other relevant career opportunities are on our jobs page.

 

Publications:

Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.

 

Highlights on Twitter this week:

For world Leprosy day we shared Manabu Ato’s VALID8 Interview, our series of infographics about Leprosy, and our video “A Vaccine for Leprosy?”. For world NTD day we shared our video “A Few Things You Might Not Know About Leishmaniasis, and some information about Melioidosis. We shared the WHO’s infographic “5 things to know about NTDs”, ASTMH recognised the 1 billion people with NTDs, and the Spanish embassy in Switzerland celebrated a joint venture that has produced a potential vaccine for canine leishmaniasis. ATCC have received FDA approval for testing a leishmaniasis vaccine, we shared the Hindustan Times’ debunking of leprosy myths, and Tanzania is embarking on a programme to eliminate leprosy by 2030. Finally, VALIDATE member Nastassja Kriel presented (via Poster) her VALIDATE-funded project M.tb biosignatures. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.

 

Published: 1 February 2023